Literature DB >> 24335007

Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis.

Izumi Iseda1, Kazuyuki Hida, Atsuhiko Tone, Masafumi Tenta, Yusuke Shibata, Kiyoshi Matsuo, Ichiro Yamadori, Kozo Hashimoto.   

Abstract

In 2011 a 76 year-old man with a medical history of diabetes, hypertension and autoimmune pancreatitis was admitted to our hospital because of anorexia, general malaise and repeated hypoglycemia. When he was 72 years old, he suffered from pancreatitis, and pancreas head tumor was operated. IgG4-related pancreatitis was diagnosed histopathologically. On admission anterior pituitary function test revealed impaired response of ACTH and cortisol to CRH, and no response of GH, TSH and gonadotropin to GHRH, TRH and LHRH, respectively. Baseline PRL level was elevated. Serum IgG and IgG4 levels were markedly elevated. Pituitary MRI showed significant enlargement of pituitary gland and stalk. Chest CT suggested IgG4-related lung disease. IgG4-related infundibulo-hypophysitis was diagnosed based on the above mentioned past history and results of present examinations. Twenty mg of hydrocortisone, followed by 20 mg of prednisolone (PSL) and 25 μg of levothyroxine markedly reduced serum IgG4 levels and ameliorated the symptom, the size of pituitary and stalk, and anterior pituitary function (TSH, GH and gonadotropin), although diabetes insipidus became apparent due to glucocorticoid administration. This is a typical case of IgG4-related hypophysitis in which PSL causes marked improvement of pituitary mass and pituitary function along with the reduction of serum IgG4 levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335007     DOI: 10.1507/endocrj.ej13-0407

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  17 in total

Review 1.  Critical review of IgG4-related hypophysitis.

Authors:  Junpei Shikuma; Kenshi Kan; Rokuro Ito; Kazuo Hara; Hiroyuki Sakai; Takashi Miwa; Akira Kanazawa; Masato Odawara
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 2.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

3.  [Clinical characteristics of central nervous system involvement in IgG4 related diseases].

Authors:  G Y Meng; Y X Zhang; Y X Zhang; Y Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

4.  MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.

Authors:  R Kurokawa; Y Ota; W Gonoi; A Hagiwara; M Kurokawa; H Mori; E Maeda; S Amemiya; Y Usui; N Sato; Y Nakata; T Moritani; O Abe
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-06       Impact factor: 3.825

5.  Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.

Authors:  Chengyu Xu; Adriana Ricciuti; Patrizio Caturegli; C Dirk Keene; Atil Y Kargi
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

6.  Histologically confirmed isolated IgG4-related hypophysitis: two case reports in young women.

Authors:  Gabriela Alejandra Sosa; Soledad Bell; Silvia Beatriz Christiansen; Marcelo Pietrani; Mariela Glerean; Monica Loto; Soledad Lovazzano; Antonio Carrizo; Pablo Ajler; Patricia Fainstein Day
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-09-01

7.  Clinical course of IgG4-related hypophysitis presenting with focal seizure and relapsing lymphocytic hypophysitis.

Authors:  Kanchana Ngaosuwan; Therdkiat Trongwongsa; Shanop Shuangshoti
Journal:  BMC Endocr Disord       Date:  2015-10-29       Impact factor: 2.763

8.  IgG4-related Hypophysitis with Subtle Hypopituitarism in an Elderly Diabetic Patient: Is Treatment or Observation Preferable?

Authors:  Motoki Kawasaki; Motoyoshi Tsujino; Fuminori Sato; Maya Sakurada; Kenji Nishida; Takayasu Kise; Yuko Hijioka; Mitsugu Ishizawa; Kazuaki Enatsu; Yoshihiro Ogawa
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

Review 9.  Neurological Manifestations of IgG4-Related Disease.

Authors:  Bernardo Baptista; Alina Casian; Harsha Gunawardena; David D'Cruz; Claire M Rice
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

10.  Deterioration of pituitary function without relapse after steroid therapy for IgG4-related hypophysitis.

Authors:  Nobuyuki Nishi; Ken Takeshima; Shuhei Morita; Hiroshi Iwakura; Masahiro Nishi; Takaaki Matsuoka
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.